Tag: senior care

————-

The following is Part 2 of a two-part series (see part one here) exploring how pharmacogenetic (PGx) testing can help senior living communities navigate medication conversations and support more personalized care. The series is written by Dr. Troy Veale, CEO of PHD Laboratory, a healthcare innovator with more than 25 years of experience in behavioral health and over a decade in laboratory science focused on advancing precision medicine and improving patient outcomes.

————-

In Part 1, we explored why medication conversations matter in senior living environments. In Part 2, we turn to the clinical side of pharmacogenetic (PGx) testing, what it is, what it is not, and why it holds particular relevance for aging populations.

WHAT PGx TESTING ACTUALLY EVALUATES

Pharmacogenetic testing analyzes specific genes that influence how medications are metabolized. Using a non-invasive cheek swab, laboratories evaluate genetic markers related to drug-processing enzymes, particularly those that impact common prescriptions used in aging adults.

Results may indicate whether an individual is likely to:

• Metabolize a medication too quickly (reducing effectiveness)
• Metabolize it too slowly (increasing side effect risk)
• Process it as expected
• Benefit from alternative medication classes

The goal is not to dictate therapy but to provide additional data to support provider judgment.

WHY AGING POPULATIONS BENEFIT FROM PERSONALIZATION

Older adults are more susceptible to adverse drug reactions for several reasons:

• Decreased liver and kidney function
• Changes in body composition
• Multiple coexisting health conditions
• Polypharmacy (use of multiple medications)

Research consistently shows that adverse drug events are a leading cause of emergency department visits among older adults. Even when medications are appropriately prescribed, genetic variation can influence response.

PGx testing brings that variability into clearer focus.

ADDRESSING COMMON MYTHS

Myth 1: PGx testing is only for complex cases.
In reality, many commonly prescribed medications,  including those for cardiovascular health, depression, pain, and neurology — have pharmacogenetic considerations.

Myth 2: Stable patients don’t need this information.
Even stable residents may benefit from minimizing long-term risk or identifying lower-risk alternatives.

Myth 3: It replaces physician expertise.
PGx testing enhances decision-making. Providers interpret results within the context of medical history and clinical presentation.

Myth 4: It is invasive or risky.
The test requires only a simple cheek swab.

BENEFITS ACROSS STAKEHOLDERS

For providers:

• Additional prescribing insight
• Support for medication adjustments
• Alignment with evidence-informed care

For senior living teams:

• Stronger educational positioning
• Confidence in discussing holistic care
• Alignment with preventative models

For families:

• Greater transparency
• Reduced uncertainty
• Peace of mind

Medication conversations become proactive rather than reactive.

PRIVACY, COVERAGE AND NEXT STEPS

Your DNA is used only to analyze how your body processes medications. PHD Laboratory does not sell, share, or store your DNA for any other purpose. We are CLIA and COLA certified and fully compliant with HIPAA privacy laws, ensuring your genetic information is protected and confidential at all times.

PGx testing is covered by Medicare Part B for eligible patients and may also be paid for using FSA/HSA funds, CareCredit, or private pay options.

For questions, educational information, or to order a PGx test, please visit the PHD Laboratory website or email info@phdlaboratory.com.

Dementia is often defined by what people lose, but a more helpful question is what abilities remain. In a recent episode of Varsity’s Roundtable Talk, Derek sat down with Teepa Snow, occupational therapist, educator and founder of Positive Approach to Care, one of the most influential voices in dementia care.

Their conversation explored why fear still shapes public perceptions of dementia, how communication must adapt as brain changes occur and why Snow prefers the term “care partner” over caregiver. She also discusses caregiver burnout and the importance of building stronger community support around people living with dementia. The following are some fresh perspectives from their conversation. Check out the full episode here. 

WHAT DOES IT MEAN TO TAKE A POSITIVE APPROACH TO DEMENTIA CARE?

Well, in my experience, I can’t use what you can’t do. It’s not possible. What I can do is engage with you and see what you have. And that’s where we can come into a relationship and I can work with you. I need to tune in to the reality of who you are now, not just who you were and what you’re capable of, because that’s what we have to work with and come together with.

WHY IS FEAR STILL THE DOMINANT EMOTION PEOPLE ASSOCIATE WITH DEMENTIA?

I think human beings, as a rule, like the predictable. They like once they master something, they don’t have to think about it so much. And I think what dementia does is rob us of our knowingness. It forces us back into a space of paying attention, being observant. The reality is dementia is ever changing. You don’t get to relax into routine. You have to stay alert, and maybe people don’t want to be on the job so much.

WHAT MISCONCEPTIONS ABOUT DEMENTIA DO THE MOST HARM?

The idea that everybody experiences the same kind of losses and changes in the same order. Alzheimer’s tends to take the front seat, but if I’m living with Lewy body or vascular dementia, my symptoms may be very different. It pays to get a pattern established of what I’m living with and how it’s going. And people also think it only happens to older adults and that it’s all about memory. Memory is just this much. There’s a whole lot more going on.

HOW EARLY SHOULD PEOPLE START LEARNING ABOUT BRAIN HEALTH AND CHANGE?

I would like us to learn more about brain health and wellness when we’re younger. Kids know their body parts, but they don’t know the brain parts, and those are super important. If I know how my brain’s supposed to work, then I can notice when it’s doing something unusual. We tend to wait until there’s so much evidence something isn’t going well, and by then we’re past screening and dealing with significant change.

WHY DO YOU PREFER THE TERM “CARE PARTNER” OVER “CAREGIVER”

I believe there is no care about me without me. It’s time to quit treating someone living with dementia like they’re a football and we’re passing them around. It’s their life, their care. I’ve got to figure out how to work with that human being. I can’t just give care because if I give it, you have to receive it. If you don’t want it, you don’t want it. So I have to partner with you.

WHAT ARE EARLY SIGNS OF CARE PARTNER BURNOUT?

If I were to ask you to tell me three things you’ve done today for yourself and you can’t, that’s a sign. If you can’t tell me something you feel good about in your relationship or something that brings you pleasure, it’s time to have a conversation. We don’t train people for this work. We drop them into it and they keep going until they drop. We need to build community around this, not expect one person to carry it all.

Want to hear more from Teepa? Check out the full episode of Roundtable Talk for more fresh perspectives. Watch new episodes of Roundtable Talk on the Varsity website and on Apple Podcasts, Spotify, and iHeartRadio.

————-

The following is Part 1 of a two-part series exploring how pharmacogenetic (PGx) testing can help senior living communities navigate medication conversations and support more personalized care. The series is written by Dr. Troy Veale, CEO of PHD Laboratory, a healthcare innovator with more than 25 years of experience in behavioral health and over a decade in laboratory science focused on advancing precision medicine and improving patient outcomes.

————-
In senior living, some of the most important conversations don’t happen on a tour, they happen around medications.

Families ask questions quietly:

• Why is Mom more tired lately?
• Is this medication causing confusion?
• Why does this prescription work for one resident but not another?

Medication management is often treated as a clinical back-office issue. But in reality, it directly affects resident satisfaction, outcomes, staff confidence, and family trust.

For senior living sales teams, executive directors, nurses, and caregivers, medication conversations present both a challenge and an opportunity. The challenge is complexity. The opportunity is education.

One emerging tool helping shift these discussions is pharmacogenetic (PGx) testing, not as a sales pitch, and not as a replacement for physician oversight, but as a framework for clearer conversations.

Why Medication Conversations Feel Overwhelming

Older adults frequently manage multiple chronic conditions, cardiovascular disease, diabetes, depression, chronic pain, neurological disorders. It is not uncommon for residents to take five, ten, or even more medications daily.

With aging comes physiological changes that affect how the body absorbs, metabolizes, and eliminates drugs. These changes can increase the risk of:

• Adverse drug reactions
• Falls and dizziness
• Increased confusion
• Medication non-adherence due to side effects
• Avoidable hospitalizations

Families often assume these risks are simply “part of aging.” Teams sometimes assume side effects are unavoidable. Providers do their best with the information available.

But what if medication conversations didn’t have to start from a place of guesswork?

A Shift Toward Personalization

PGx testing evaluates how a person’s genetics may influence the way certain medications are processed in the body. It doesn’t diagnose disease. It doesn’t predict future illness. It provides insight into how medications may interact with an individual’s metabolic profile.

For senior living professionals, the most powerful part of PGx testing isn’t the lab result, it’s the conversation it opens.

It creates space to ask:

• Is this medication optimal for this individual?
• Could side effects be reduced?
• Are there alternatives that may align better?
• How can we support safer prescribing conversations?

These are not clinical determinations made by sales staff or caregivers. They are informed discussions that support provider evaluation and collaborative care planning. 

Trust Is Built Through Transparency

Senior living is built on trust. Families are not just choosing a community; they are choosing partners in care.

When medication conversations are proactive rather than reactive, families feel:

• Heard
• Educated
• Involved
• Reassured

Communities that introduce the idea of personalized medication discussions demonstrate alignment with preventative and value-based care models.

Sales teams are uniquely positioned here. They can frame PGx testing as a supportive educational resource, one that enhances provider decision-making and resident well-being.

Rather than saying, “We offer genetic testing,” the conversation becomes:

“We believe in helping families feel confident in every aspect of care — including medications.”

Removing Barriers, Not Adding Complexity

One concern often raised is whether introducing PGx testing adds another layer of complexity to an already overwhelming process. The opposite can be true.

By helping providers evaluate medication suitability earlier rather than later, PGx testing may reduce future medication adjustments, side effects, or avoidable emergency visits. It simplifies long-term decision-making by introducing clearer data into the process.

For caregivers and daughters like Michele, who recently navigated placing her own mother into senior living, clarity around medications is deeply personal. Families want assurance that their loved one is not simply “trying medications”, but receiving informed, thoughtful care.

PGx testing supports that reassurance.

A New Category of Conversation

Senior living has evolved to include partnerships in move management, downsizing, care coordination, and wellness programming. Medication personalization is a natural extension of holistic senior care.

This isn’t about replacing physicians. It isn’t about overstepping clinical boundaries. It’s about strengthening education, transparency, and collaboration.

In Part 2, we will explore the clinical foundation behind PGx testing, how it works, common myths, and why it continues gaining traction in aging populations.

Privacy, Coverage, and Next Steps

Your DNA is used only to analyze how your body processes medications. PHD Laboratory does not sell, share, or store your DNA for any other purpose. We are CLIA and COLA certified and fully compliant with HIPAA privacy laws, ensuring your genetic information is protected and confidential at all times.

PGx testing is covered by Medicare Part B for eligible patients and may also be paid for using FSA/HSA funds, CareCredit, or private pay options.

For questions, educational information, or to order a PGx test, please visit the PHD Laboratory website or email info@phdlaboratory.com.